ValuEngine lowered shares of Alcentra Capital (NASDAQ:ABDC) from a hold rating to a sell rating in a report published on Thursday morning.
NASDAQ:ABDC opened at $5.82 on Thursday. Alcentra Capital has a fifty-two week low of $5.58 and a fifty-two week high of $9.01. The firm has a market cap of $78.74 million, a PE ratio of 5.11 and a beta of 0.59.
Alcentra Capital (NASDAQ:ABDC) last posted its quarterly earnings results on Monday, August 6th. The asset manager reported $0.25 earnings per share for the quarter, topping the Zacks’ consensus estimate of $0.20 by $0.05. Alcentra Capital had a negative net margin of 43.78% and a positive return on equity of 10.10%. The business had revenue of $7.25 million for the quarter, compared to analysts’ expectations of $6.82 million. Research analysts predict that Alcentra Capital will post 0.94 earnings per share for the current year.
Several large investors have recently bought and sold shares of ABDC. Belpointe Asset Management LLC acquired a new stake in Alcentra Capital in the 2nd quarter valued at about $107,000. Salzhauer Michael grew its stake in Alcentra Capital by 100.8% in the 2nd quarter. Salzhauer Michael now owns 247,178 shares of the asset manager’s stock valued at $910,000 after acquiring an additional 124,057 shares during the last quarter. Finally, Bank of New York Mellon Corp grew its stake in Alcentra Capital by 17.6% in the 2nd quarter. Bank of New York Mellon Corp now owns 629,022 shares of the asset manager’s stock valued at $4,019,000 after acquiring an additional 94,111 shares during the last quarter. 33.59% of the stock is currently owned by institutional investors and hedge funds.
Alcentra Capital Company Profile
Alcentra Capital Corporation is a business development company specializing in investments in lower middle-market companies. The fund seeks to invest in healthcare, business services, defense, government services, telecom and technology, media, infrastructure maintenance and logistics, and oil and gas services sector.
See Also: Find a Trading Strategy That Works
To view ValuEngine’s full report, visit ValuEngine’s official website.
Receive News & Ratings for Alcentra Capital Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Alcentra Capital and related companies with MarketBeat.com's FREE daily email newsletter.